Features

Latest Features

HIV/AIDS Generic HIV Medicines: Boon or Bust?

Generic HIV Medicines: Boon or Bust?

Generic antiretroviral agents have had a dramatic effect on outcomes in developing nations, and their availability in developed countries is rapidly expanding as more brand-name drugs are coming off patent. But unique challenges surrounding their use remain.

Influenza Improving Efforts to Prepare for Influenza Epidemics

Improving Efforts to Prepare for Influenza Epidemics

Although substantial emphasis is placed on vaccinations in considering how to limit the spread of influenza, simple hygienic methods have been found to be the most effective and should be more widely supported.

Hepatitis Advisor Closing the Gap in Managing Viral Hepatitis Infections in Refugees and Immigrants

Closing the Gap in Managing Viral Hepatitis Infections in Refugees and Immigrants

To meet the goals of the World Health Organization for reducing new infections and decreasing deaths associated with hepatitis B and C virus by 2030, people on the margins of society will need to be tested and treated, including refugees and migrants from endemic regions, as well as people who inject drugs.

Antibiotics, Antimicrobial Resistance Role of Vaccines in the Fight Against Antimicrobial Resistance

Role of Vaccines in the Fight Against Antimicrobial Resistance

The potential role of vaccinations in combatting antimicrobial resistance (AMR) is currently undervalued. The distribution and development of new vaccines should be priorities in efforts to address the AMR crisis.

Skin Infections When to Suspect GBS Cellulitis and Necrotizing Fasciitis in Infants

When to Suspect GBS Cellulitis and Necrotizing Fasciitis in Infants

GBS infections in infants, cellulitis and necrotizing fasciitis, although uncommon in infants, requires swift treatment with antibiotics and occasionally surgical debridement.

HIV/AIDS Emerging Technologies to Manage Antiretroviral Therapy Adherence

Emerging Technologies to Manage Antiretroviral Therapy Adherence

The rapidly developing landscape of antiretroviral therapy adherence monitoring has great potential for clinical application, but cost-effectiveness and feasibility studies are needed to define the appropriate roles for these new technologies.

Vector-borne Illnesses Malaria Therapy During Pregnancy Needs a Translational Booster

Malaria Therapy During Pregnancy Needs a Translational Booster

First trimester treatment for malaria could change with the results of 1 of the most robust meta-analyses to date that compared artemisinin-based therapy vs quinine.

Antibiotics, Antimicrobial Resistance Combating Medically Important Antibiotic Use in Food-Producing Animals

Combating Medically Important Antibiotic Use in Food-Producing Animals

The new WHO guidelines restricts antibiotic use in animals for purposes of growth promotion as well as avoidance of use for disease prevention.

Pneumonia Pneumonia: Inflammation Linked to Cardiovascular Complications

Pneumonia: Inflammation Linked to Cardiovascular Complications

Community-acquired pneumonia and other acute infections can cause or exacerbate cardiovascular complications.

Treatments Treating Acute Urinary Tract Infection in Postmenopausal Women

Treating Acute Urinary Tract Infection in Postmenopausal Women

Expert perspective on management and treatment of acute urinary tract infections in postmenopausal women.

Vector-borne Illnesses Major Advances on Horizon for Tick-Borne Disease Testing

Major Advances on Horizon for Tick-Borne Disease Testing

Prompt diagnosis of tick-borne diseases is essential but testing methods have been imprecise. Learn about some recent testing advances for Lyme disease and other tick-borne illnesses.

HIV/AIDS Advisor Inflammation May Hold Key to Noncommunicable Disease in HIV

Inflammation May Hold Key to Noncommunicable Disease in HIV

As more deaths among individuals living with HIV are not directly associated with communicable diseases, the influence of sex hormones and inflammation on morbidity is coming under scrutiny.

Sepsis Sepsis Recovery Requires an All-Hands Approach

Sepsis Recovery Requires an All-Hands Approach

After hospital discharge for sepsis, the healthcare team should focus on identifying new functional, mental, and cognitive impairments and referring patients to appropriate treatment; reviewing and adjusting long-term medications; and evaluating for treatable conditions that commonly result in hospitalizations.

Hepatitis Advisor Managing HBV Infection Following Liver Transplant: Expert Q&A

Managing HBV Infection Following Liver Transplant: Expert Q&A

In the past 2 decades, prophylactic antiviral therapies have drastically reduced the rates of HBV recurrence, allograft loss, and mortality in patients undergoing liver transplantation.

Hepatitis Advisor Evolving Recognition of Chronic Hepatitis C Infection as a Modifiable Risk Factor for CVD

Evolving Recognition of Chronic Hepatitis C Infection as a Modifiable Risk Factor for CVD

Review of subclinical and clinical cardiovascular diseases in patients with chronic hepatitis C infection.

Hepatitis Advisor HCV in Older Adults: Effects of Prolonged Infection, Aging-Related Mechanisms, and Treatment

HCV in Older Adults: Effects of Prolonged Infection, Aging-Related Mechanisms, and Treatment

Despite worse outcomes in older adults, treatment efficacy and safety of direct-acting antivirals appear to be similar between older adults and younger patients, based on limited available data. Age should not be considered a barrier to treatment in older HCV-infected adults.

Sexually Transmitted Diseases Antibiotic-Resistant Gonorrhea: Prevention Strategies for a Growing Threat

Antibiotic-Resistant Gonorrhea: Prevention Strategies for a Growing Threat

Learn about drugs in the pipeline for treatment-resistant gonorrhea.

HIV/AIDS Advisor HIV in Neonates: Additional Treatment Options Needed

HIV in Neonates: Additional Treatment Options Needed

The goal of ART in neonates has expanded from reducing morbidity and mortality to the possibility of facilitating remission, but further research is needed to advance this goal, and additional treatment options are also needed for this population.

Hepatitis Advisor Simplifying Viral Hepatitis Testing Will Slow the Spread of Disease

Simplifying Viral Hepatitis Testing Will Slow the Spread of Disease

Experts from the World Health Organization and the London School of Hygiene and Tropical Medicine in the United Kingdom discuss the imperative to stop viral hepatitis, current diagnostic challenges, and the future of testing.

Treatments Reason for Hope: Promising Gram-Negative Infection Treatments in the Pipeline

Reason for Hope: Promising Gram-Negative Infection Treatments in the Pipeline

Dr McKinnell provides a summary of drugs in development for infections caused by Gram-negative bacteria, including carbapenem-resistant Pseudomonas aeruginosa and carbapenem-resistant Enterobacteriaceae.

Prevention Strategies for Preventing Group B Streptococcus in Infants

Strategies for Preventing Group B Streptococcus in Infants

Expert from the National Center for Immunization and Respiratory Diseases, a division of the CDC, discusses prevention strategies for group B streptococcus in infants, including the development of a maternal vaccine.

Hepatitis Advisor Generic DAAs: A Step Closer to Eradicating HCV in Lower-Income Countries

Generic DAAs: A Step Closer to Eradicating HCV in Lower-Income Countries

The availability of low-cost generic DAAs in lower income countries are a major step forward in combating HCV in these countries, but substantial work is still needed to put the WHO's goal of HCV elimination by 2030 within reach.

HIV/AIDS Vagus Nerve Stimulation May Improve HIV-Associated Depression

Vagus Nerve Stimulation May Improve HIV-Associated Depression

Transcutaneous vagus nerve stimulation could provide a safe alternative treatment in HIV-depression by targeting both depression and other comorbidities that can burden people living with HIV.

Influenza Universal Influenza Vaccine: A Game Changer in Prevention

Universal Influenza Vaccine: A Game Changer in Prevention

A dedicated research effort led by NIH's National Institute of Allergy and Infectious Diseases is aimed at developing a universal influenza vaccine that would confer better and longer-lasting protection against influenza virus strains.

Practice Management Machine Learning Algorithms in Medicine: What Are the Pitfalls?

Machine Learning Algorithms in Medicine: What Are the Pitfalls?

Experts discusses the potential pitfalls of machine learning algorithms in medicine.

Practice Management Conscious vs Unconscious Decision-Making in Medicine

Conscious vs Unconscious Decision-Making in Medicine

Evaluating conscious vs unconscious decision making in medicine.

Practice Management Effects of Computerized Decision Support Systems in Medicine

Effects of Computerized Decision Support Systems in Medicine

Evaluating the effects of computerized decision support systems in medicine.

Practice Management Bias in Clinical Research: The Streetlight Effect

Bias in Clinical Research: The Streetlight Effect

Evidence of the streetlight effect can be found across several fields, from physics and astronomy, to economics, in which cases investigators draw suspect conclusions from analysis of irrelevant data. Medicine, unsurprisingly, has not been immune, particularly in cancer research.

Practice Management Healthcare Inequality in America: What Are the Contributing Factors?

Healthcare Inequality in America: What Are the Contributing Factors?

Differences in life expectancy have widened between wealthy and low-income Americans: the poorest 1% of citizens have a life expectancy 10.1 years and 14.6 years shorter for women and men, respectively, compared with the richest 1%.

Pediatric Illnesses Pediatric Urinary Tract Infection: Diagnostic and Treatment Challenges

Pediatric Urinary Tract Infection: Diagnostic and Treatment Challenges

Experts discuss the various imaging modalities for children who require diagnostic workup beyond urine culture, as well as the consequences of overusing antibiotics and antibiotic route of administration.

Pneumonia Routine Chest Radiographs Not Recommended in Suspected Pediatric Pneumonia

Routine Chest Radiographs Not Recommended in Suspected Pediatric Pneumonia

Chest X-rays do not differentiate between viral and bacterial pathogens, and they do not subsequently alter the course of treatment.

Hepatitis Treatment Regimens and Recommendations for HIV/HCV Coinfection

Treatment Regimens and Recommendations for HIV/HCV Coinfection

Experts discuss the management of drug-drug interactions in patients receiving treatment for HIV and HCV coinfection.

HIV/AIDS Can We Prevent HIV and STIs Through School Programs?

Can We Prevent HIV and STIs Through School Programs?

Although a positive impact on behavior change has been reported following the implementation of curriculum-based programs, there is a lack of clear evidence that school-based educational interventions directly prevent HIV/STIs.

Influenza Can the Influenza Vaccine Prevent Acute Otitis Media?

Can the Influenza Vaccine Prevent Acute Otitis Media?

Vaccination may confer modest reductions in acute otitis media (AOM) and AOM-targeted antibiotic use but use of influenza vaccine as a strategy to reduce AOM is likely unjustified.

HIV/AIDS How HIV Affects Cervical Cancer Risk and Outcomes

How HIV Affects Cervical Cancer Risk and Outcomes

Women with HIV have an increased risk for persistent HPV infection, which frequently progresses to cervical cancer, and they should be warned of their increased risk for HPV and cervical cancer and, when appropriate, advised to undergo HPV vaccination.

Emerging Diseases Climate Change: Effects on the Incidence and Distribution of Infectious Diseases

Climate Change: Effects on the Incidence and Distribution of Infectious Diseases

Without proactive measures and response, the changing climate is projected to continue to adversely affect the global incidence and distribution of infectious diseases and cause 250,000 additional deaths per year between 2030 and 2050.

Diagnostics MicroRNAs in Infectious Disease: Emerging Clinical Applications

MicroRNAs in Infectious Disease: Emerging Clinical Applications

MicroRNAs are currently under investigation for various clinical applications in infectious disease because of their role in host response to infection and effects on innate and adaptive immune pathways.

HIV/AIDS Pausing ART to Identify Biomarkers for HIV RNA Rebound: Safety and Ethical Considerations

Pausing ART to Identify Biomarkers for HIV RNA Rebound: Safety and Ethical Considerations

Dr Gianella Weibel talks with Dr Li and Dr Dubé, investigators of a new study from the AIDS Clinical Trials Group, which uses an intensively monitored antiretroviral pause to identify changes in HIV reservoirs after anti-HIV medications are stopped.

Sexually Transmitted Diseases Seminal HPV Infection Prevalent Worldwide, May Affect Male Fertility

Seminal HPV Infection Prevalent Worldwide, May Affect Male Fertility

Study was the first to examine the geographical variation of seminal HPV prevalence, showing a relatively high prevalence in fertility clinic attendees when compared to the general population.

Prevention Improving Campaigns Regarding the Value of Adult Vaccines

Improving Campaigns Regarding the Value of Adult Vaccines

Educational campaigns regarding the value of vaccines should go beyond facts and statistics to integrating social psychological considerations with health communication principles.

Influenza Fast Track Designation for Novel Monoclonal Antibody Targeting Influenza A

Fast Track Designation for Novel Monoclonal Antibody Targeting Influenza A

The FDA has granted Fast Track designation to Visterra's lead product, VIS410.

Hepatitis The Changing Face of HCV: Role of the Opioid Epidemic

The Changing Face of HCV: Role of the Opioid Epidemic

The opioid epidemic has fueled the transmission of HCV, particularly among younger persons, who are often unaware of their risks and prevented from receiving timely treatment due to a variety of care barriers, even in settings ideally suited to identifying and treating HCV.

Respiratory Update on Latent Tuberculosis Testing and Treatment

Update on Latent Tuberculosis Testing and Treatment

A representative from the California Department of Public Health discusses latent TB infection testing and treatment recommendations and reasons why US physicians have been slow to test for and treat for the condition.

Regulatory Issues New Regulations and Code of Ethics for Research in the 21st Century

New Regulations and Code of Ethics for Research in the 21st Century

The 2017 revisions to the Common Rule deal largely with improving the transparency and clarity of intended uses under the current standard of informed consent, while introducing a new concept of "broad consent."

Hepatitis Racial Disparities in HCV Incidence and Treatment Outcomes

Racial Disparities in HCV Incidence and Treatment Outcomes

Racial disparities in HCV treatment outcomes can be partially explained by the differences in underlying immune/genetic characteristics of patients.

Antibiotics, Antimicrobial Resistance Antibiotic Innovation Is Losing Ground to Gram-Negative Bacteria

Antibiotic Innovation Is Losing Ground to Gram-Negative Bacteria

Experts discuss antibiotic classes in development, which agents holds the most promise, and how to prevent further resistance.

HIV/AIDS Linkage to HIV Care: To Give or Not to Give Financial Incentives?

Linkage to HIV Care: To Give or Not to Give Financial Incentives?

Use of incentives makes the most sense with disadvantaged populations including homeless, drug users, and people in developing countries.

Vector-borne Illnesses A New Generation of Challenges for the Traditional Yellow Fever Vaccine

A New Generation of Challenges for the Traditional Yellow Fever Vaccine

There is no cure or even effective antiviral therapy for yellow fever. Vaccination remains the sole route for preventing mortality from the disease, and WHO projections have already pointed to a significant global shortage.

Vector-borne Illnesses When and How to Test for Lyme Disease, a Growing Threat

When and How to Test for Lyme Disease, a Growing Threat

Diagnosing Lyme disease can be difficult because symptoms vary from one person to another and can resemble symptoms of other infectious diseases spread by ticks.

Nosocomial Infections Treatment of Neurologic Complications in Infective Endocarditis

Treatment of Neurologic Complications in Infective Endocarditis

Mortality rates associated with infective endocarditis range from 16% to 25%, with the highest rates observed among patients with nosocomial healthcare-associated infective endocarditis.

Ebola Evidence-Based Guidelines for Supportive Care in Ebola Treatment

Evidence-Based Guidelines for Supportive Care in Ebola Treatment

First-hand accounts of the care that was delivered during the 2013-16 West African outbreak of Ebola virus disease provided impetus for these guidelines.

Respiratory Challenges in Diagnosing Tuberculous Meningitis

Challenges in Diagnosing Tuberculous Meningitis

Diagnosis of tuberculous meningitis is challenging, although new, next-generation rapid POC testing holds promise for greatly improved sensitivity. Shorter and more effective treatments are needed.

GI Illness IDSA Updates Infectious Diarrhea Guidelines

IDSA Updates Infectious Diarrhea Guidelines

The Infectious Diseases Society of America updated its guidelines for the management of acute or persistent infectious diarrhea.

Hepatitis Short-Duration Treatment Regimens for Chronic HCV: Latest Insights

Short-Duration Treatment Regimens for Chronic HCV: Latest Insights

The high cost of DAA-based regimens remains an ethical issue and an obstacle to treatment accessibility. Shorter treatment regimens may offer substantial cost savings, improved treatment adherence, and a reduced rate of side effects.

Emerging Treatments Once-Daily Raltegravir Safe, Effective for Initial HIV Treatment

Once-Daily Raltegravir Safe, Effective for Initial HIV Treatment

Once-daily regimens have been shown to improve adherence to treatment with no adverse effect on outcomes in patients with HIV.

Hepatitis Challenges in Treating Genotype 3 Hepatitis C Virus

Challenges in Treating Genotype 3 Hepatitis C Virus

Data have shown patients with genotype 3 HCV have faster progression of fibrosis and higher rates of cirrhosis, severe steatosis, and hepatocellular carcinoma.

Waterborne Illnesses Typhoid Conjugate Vaccine Protective Against Oral Salmonella Typhi Challenge

Typhoid Conjugate Vaccine Protective Against Oral Salmonella Typhi Challenge

Investigators review results from the first study to assess the efficacy of a Vi-conjugate vaccine using a controlled human infection model of typhoid fever.

GI Illness Better Detection and Treatment Needed for H pylori Infections in Children

Better Detection and Treatment Needed for H pylori Infections in Children

In recent years, a link between childhood Helicobacter pylori and gastric cancer in adulthood has elevated the need to detect and treat H pylori in asymptomatic children.

Chlamydia Vaginal Microbiota Profile Predictive of Chlamydia Susceptibility

Vaginal Microbiota Profile Predictive of Chlamydia Susceptibility

Vaginal microbiota dominated by L iners has been shown to exhibit rapid change in composition in and out of community states similar to bacterial vaginosis.

Antibiotics, Antimicrobial Resistance Are Antibiotic Stewardship Programs the Antidote to Antibiotic Overuse?

Are Antibiotic Stewardship Programs the Antidote to Antibiotic Overuse?

Optimizing outcomes with an antibiotic stewardship programs requires a team approach that involves point-of-care providers.

Antibiotics, Antimicrobial Resistance Strategies for Preventing Antibiotic Resistance in Acne

Strategies for Preventing Antibiotic Resistance in Acne

Physicians can help avoid contributing to antibiotic resistance by recognizing and using appropriate alternative treatments, and having a strategy so that patients are not on antibiotics for a long period of time.

HIV/AIDS Assessing the Risk Factors of Neurocognitive Decline in HIV+ Individuals

Assessing the Risk Factors of Neurocognitive Decline in HIV+ Individuals

The incidence of neurocognitive impairment is high in HIV-infected population, despite the introduction of combination antiretroviral therapy (CART).

Hepatitis Treating Hepatocellular Carcinoma: A Fight Against the Odds

Treating Hepatocellular Carcinoma: A Fight Against the Odds

Despite continual efforts aimed at finding new treatment options, HCC still has a very low 5-year survival rate, less than 20%, as many patients are diagnosed at an advanced stage of the disease.

Skin Infections No Difference in Adverse Events Between Delafloxacin or Vancomycin/Aztreonam in ABSSSI

No Difference in Adverse Events Between Delafloxacin or Vancomycin/Aztreonam in ABSSSI

Incidence of adverse events with delafloxacin (Baxdela™, Melinta Therapeutics) was comparable to the combination regimen of vancomycin plus aztreonam across 2 phase 3 registrational ABSSSI studies.

Pneumonia Updated Guidelines for Management of Hospital-Acquired/Ventilator-Associated Pneumonia

Updated Guidelines for Management of Hospital-Acquired/Ventilator-Associated Pneumonia

An international panel of experts applied the GRADE system and choose 7 PICO questions to generate recommendations for HAP/VAP.

HIV/AIDS Why Patients Discontinue ART— and What You Can Do to Stop It

Why Patients Discontinue ART— and What You Can Do to Stop It

Learn more about when stopping antiretroviral therapy (ART) may be necessary, why patients discontinue ART, predicting viral suppression, and predicting and encouraging adherence.

MRSA Routine Evidence-Based Care for S aureus Infection Improves Survival

Routine Evidence-Based Care for S aureus Infection Improves Survival

Increase use of evidence-based care processes decreased mortality associated with S aureus bacteremia in VHA hospitals.

Antibiotics, Antimicrobial Resistance Delafloxacin Shows High Response Rates in Fluoroquinolone-resistant S aureus

Delafloxacin Shows High Response Rates in Fluoroquinolone-resistant S aureus

New data confirms delafloxacin shows high response rates against MRSA.

Hygiene Three-Part Strategy Announced for Hepatitis A Outbreak

Three-Part Strategy Announced for Hepatitis A Outbreak

A 3-part strategy was announced to combat the hepatitis A outbreak in San Diego, California.

HIV/AIDS Bone Loss and Fracture Risk in Patients With HIV: What We Know So Far

Bone Loss and Fracture Risk in Patients With HIV: What We Know So Far

In addition to prevention measures, switching off the ARTs associated with bone loss and administering intravenous bisphosphonate, a bone resorption inhibitor, can be an effective strategy for preventing bone loss seen in HIV-infected individuals.

Practice Management Ransomware Attacks in Medicine: Are Hospitals Adequately Protected?

Ransomware Attacks in Medicine: Are Hospitals Adequately Protected?

How can hospitals protect themselves against recent ransomware attacks?

Hepatitis Hepatitis B: Search for the Cure and Challenges That Remain

Hepatitis B: Search for the Cure and Challenges That Remain

One of the main challenges in managing and controlling hepatitis B infection today is identifying people who are infected and ensuring that they have access to suitable treatment.

Practice Management Accountable Care Organizations: Evaluating Cost Saving Success

Accountable Care Organizations: Evaluating Cost Saving Success

An analysis on the cost saving success of accountable care organizations.

Respiratory M tuberculosis Disrupts Regulatory Macrophage Pathways Driving Immunopathology

M tuberculosis Disrupts Regulatory Macrophage Pathways Driving Immunopathology

Mycobacterium tuberculosis engages the host immune response to drive immunopathology and tissue destruction by disrupting negative regulatory pathways in human macrophages.

Nosocomial Infections Follow-up Blood Culture in Gram-Negative Bacteremia Should Be Avoided

Follow-up Blood Culture in Gram-Negative Bacteremia Should Be Avoided

Follow-up blood cultures may have little utility in the management of Gram-negative bacilli bacteremia, according to data from a recent study.

GI Illness CDC Issues Advisory on the Rise of Cyclosporiasis

CDC Issues Advisory on the Rise of Cyclosporiasis

The CDC Health Alert Network has issued an advisory regarding an increase in cases of the intestinal illness cyclosporiasis.

Sexually Transmitted Diseases Mycoplasma genitalium: Challenges in Diagnosis and Treatment

Mycoplasma genitalium: Challenges in Diagnosis and Treatment

While Mycoplasma genitalium is emerging as one of the most common causes of sexually transmitted infections, and is often underrecognized and treated with ineffective antibiotics.

Vector-borne Illnesses Second Dose of Tetravalent Dengue Vaccine Candidate Shows Enhanced Immunogenicity

Second Dose of Tetravalent Dengue Vaccine Candidate Shows Enhanced Immunogenicity

A tetravalent dengue vaccine candidate (TDV) was found to be safe and immunogenic in an ongoing phase 2 trial. A second TDV dose induced enhanced immunogenicity against DENV-3 and DENV-4 in children who were seronegative before vaccination, supporting the initiation of phase 3 trial to evaluate the efficacy and safety of TDV given in a 2-dose schedule 3 months apart.

Clostridium Difficile Biotherapeutics for the Prevention of Clostridium difficile Infection

Biotherapeutics for the Prevention of Clostridium difficile Infection

Experts review biotherapeutics for the prevention of C difficile infection, including probiotics, fecal microbiota transplantation, and nontoxigenic C difficile.

Hepatitis Hepatitis C Virus Infection and Cardiovascular Disease Risk

Hepatitis C Virus Infection and Cardiovascular Disease Risk

Epidemiological data demonstrate a link between HCV infection and cardiovascular disease, whereas treatment studies suggest viral eradication may lower the risk for cardiovascular morbidity and mortality.

Pneumonia Challenges in Managing Hospital-Acquired Pneumonia

Challenges in Managing Hospital-Acquired Pneumonia

Diagnosis is one of the primary difficulties in managing hospital acquired pneumonia.

Hepatitis New Treatment Options for Rheumatic Manifestations of HCV

New Treatment Options for Rheumatic Manifestations of HCV

Patients with HCV are at risk for several extrahepatic sequelae. Find out what they are and the new treatment options for managing HCV in patients with rheumatic symptoms.

Pediatric Illnesses CMV Infection in Mothers and Infants: Diagnostic and Treatment Challenges

CMV Infection in Mothers and Infants: Diagnostic and Treatment Challenges

Cytomeglovirus infection is associated with a range of diagnostic and treatment challenges and a relatively high transmission rate from the mother to the fetus.

HIV/AIDS ART and PrEP: How Technological Advances Can Improve Adherence

ART and PrEP: How Technological Advances Can Improve Adherence

Several technological advances have been developed to improve adherence to antiretroviral and preexposure prophylaxis therapy.

Infections in Immunocompromised Patients Infections Complicate Biologic Use in Autoimmune Inflammatory Disorders

Infections Complicate Biologic Use in Autoimmune Inflammatory Disorders

The risk for infection and malignancy associated with biologic use complicates the management of patients with a deficient immune system. Equip yourself with the information needed to effectively manage these complex patients.

Sepsis Sepsis-Related Mortality Decreased With Rapid Implementation of Protocol

Sepsis-Related Mortality Decreased With Rapid Implementation of Protocol

Rapid treatment of sepsis using mandated care bundles improves outcomes.

Diagnostics Advances in Point-of-Care Testing and Tips for Clinicians

Advances in Point-of-Care Testing and Tips for Clinicians

An expert interview on recent developments in molecular point-of-care and near-patient testing for infectious diseases.

Sexually Transmitted Diseases New Assay Targets Susceptibility to Ciprofloxacin in Gonorrhea

New Assay Targets Susceptibility to Ciprofloxacin in Gonorrhea

In an effort to combat extensive drug-resistance in gonorrhea, a new assay identifies patients who may still have a response to an older, less reliable therapy.

Geriatric Illnesses Gut Microbiota Associated With Parkinson's Disease Progression

Gut Microbiota Associated With Parkinson's Disease Progression

An imbalance in gut microbiota may be associated with the progression of Parkinson's disease.

HIV/AIDS Last Gift Study: A Participant's Perspective on End-of-Life HIV Research

Last Gift Study: A Participant's Perspective on End-of-Life HIV Research

Dr Sara Gianella Weibel talks with Anthony B, a patient with HIV and end-stage amyotrophic lateral sclerosis and the first participant enrolled in the "Last Gift" end-of-life study, about his experience as part of this new end-of-life model to study HIV persistence.

HIV/AIDS Last Gift Study: Community Perspective on End-of-Life HIV Research

Last Gift Study: Community Perspective on End-of-Life HIV Research

Dr Sara Gianella Weibel talks with Jeff Taylor, community activist and long-term HIV survivor, about a new end-of-life model to study HIV persistence.

HIV/AIDS Last Gift Study: End-of-Life HIV Research

Last Gift Study: End-of-Life HIV Research

Dr Sara Gianella Weibel talks with Dr Davey Smith, head of the Division of Infectious Disease at the University of California, San Diego, about a proposed new model to study HIV persistence, called the Last Gift study.

Clostridium Difficile C difficile Treatment and Prevention: Novel Antibiotics and Immunologic Therapies

C difficile Treatment and Prevention: Novel Antibiotics and Immunologic Therapies

Experts review novel antibiotic therapies that may limit the impact on the gut microbiome, as well as passive immunization products that may bolster the immune response to C difficile toxins and possibly reduce the frequency of toxigenic strains.

Hepatitis Hepatitis C Virus Infection: A Risk Factor for Type 2 Diabetes?

Hepatitis C Virus Infection: A Risk Factor for Type 2 Diabetes?

Hepatitis C virus infection may increase the risk for type 2 diabetes, but whether a causal relationship exists is unclear. Screening for type 2 diabetes in this population may have important public health implications.

Practice Management Addressing Challenges of Medical Liability Reform

Addressing Challenges of Medical Liability Reform

Medical liability remains a troubling issue today, placing a burden on patients and a financial burden of medical practitioners and insurance providers.

Pneumonia Efficacy of Antibiotics for Community-Acquired Pneumonia Evaluated

Efficacy of Antibiotics for Community-Acquired Pneumonia Evaluated

Study finds that over one-fifth of those prescribed an antibiotic for community-acquired pneumonia experience treatment failure.

HIV/AIDS A Transgender Woman's Perspective on HIV Research, Prevention, and Care

A Transgender Woman's Perspective on HIV Research, Prevention, and Care

Dr Sara Gianella talks with Brooke Sullivan, a transgender woman and HIV activist, about ways to improve transgender individuals' involvement in HIV research.

HIV/AIDS PrEP in the Transgender Population: New Study to Examine Effects

PrEP in the Transgender Population: New Study to Examine Effects

Dr Sara Gianella talks with Dr Sheldon Morris, from the University of California San Diego AntiViral Research Center about an upcoming PrEP study in transgender people, including understanding HIV prevention in this population, uptake of PrEP, and adherence to treatment.

Regulatory Issues Congressional Acts Pose Threat to National ID Health Initiatives

Congressional Acts Pose Threat to National ID Health Initiatives

Passage of the 2017 budget, along with congressional approval of the AHCA, leaves large holes in the funding of the proposed national approach to infectious disease control.

HIV/AIDS HIV Transmission Through Breastfeeding: New Review and Expert Interview

HIV Transmission Through Breastfeeding: New Review and Expert Interview

Mother-to-child HIV transmission rates are low in the presence of antiretroviral therapy but increase once ART stops at 6 months postpartum.

Sign Up for Free e-newsletters